Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug repurposing clinical trial initiative for Parkinson’s disease.  

About The Study: In this cohort of patients with type 2 diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use was associated with significantly lower risks of vertebral compression fractures and related surgical interventions compared with nonuse, suggesting bone protective benefits of GLP-1 RAs. 

About The Study: Consistent with prior work, this study found low adherence (7.3%) to cervical cancer screening guidelines among the commercially insured U.S. population despite stable coverage, likely reflecting guideline confusion among patients, clinicians, and health systems. More evidence-based strategies are needed to expand capacity for guideline-adherent screening, reduce over-screening, and align payer and health system incentives, particularly as new modalities, such as human papillomavirus (HPV) self-sampling, emerge.

A molecule involved in red blood cell production determines whether the immune system attacks or ignores cells in the body via peripheral immune tolerance, Stanford Medicine-led research finds.

Scientists collected and analyzed lung samples from pneumonia patients. Samples fell into one of four distinct microbial patterns. Lung microbiomes resembling oral microbiomes were associated with recovery. Dynamic, rather than static, microbiomes also were associated with recovery.

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and influence outcomes. Overall, the findings, published Dec. 10, 2025, in Nature, describe a previously unknown origin of some aggressive lung cancers.